Viewing Study NCT05997056

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:33 PM
Ignite Modification Date: 2025-12-29 @ 10:48 PM
Study NCT ID: NCT05997056
Status: RECRUITING
Last Update Posted: 2024-07-16
First Post: 2023-08-10
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Trial of Nab-sirolimus in Patients With Well-differentiated Neuroendocrine Tumors (NETs) of the Gastrointestinal Tract, Lung, or Pancreas Who Have Not Received Prior Treatment With mTOR Inhibitors
Sponsor: Aadi Bioscience, Inc.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Neuroendocrine Tumors View
None NET View
None Pancreatic Neuroendocrine Tumor View
None Gastrointestinal Neuroendocrine Tumor View
None Pulmonary Neuroendocrine Tumor View
Keywords:

Keywords

Keyword Brief Keyword Text View
None FYARRO View
None nab-sirolimus View
None ABI-009 View
None Neuroendocrine Tumors View
None NET View
None Pancreatic Neuroendocrine Tumor View
None Gastrointestinal Neuroendocrine Tumor View
None Pulmonary Neuroendocrine Tumor View